Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and headlines.

Drug News

Added 18 hours ago Drug news

Overall survival results from PACIFIC Phase III trial of Imfinzi in unresectable stage III NSCLC.- AstraZeneca.

AstraZeneca and MedImmune, its global biologics research and development arm, announced positive overall survival (OS) results for the Phase III...

Added 18 hours ago Drug news

Phase III iLLUMINATE trial report of Imbruvica + Gazyva combination for chronic lymphocytic leukemia or small lymphocytic lymphoma.- Abbvie + Janssen Biotech

AbbVie has announced that the Phase III iLLUMINATE (PCYC-1130) trial met its primary endpoint of improvement in progression-free survival (PFS)....

Added 1 day ago Drug news

FDA approves Palynziq to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (PKU).- BioMarin.

BioMarin Pharmaceutical Inc. announced that BioMarin received standard approval from the FDA for Palynziq™ (pegvaliase-pqpz) Injection to reduce blood phenylalanine...

Added 1 day ago Drug news

Retrospective effectiveness study positive for Saxenda in weight reduction.- Novo Nordisk.

People treated with Saxenda (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in...

Industry news

Added 10 days ago Industry news

Tapimmune Inc. to merge with Marker Therapeutics.

TapImmune Inc.announced that it has entered into a definitive merger agreement to acquire Marker Therapeutics a privately-held clinical-stage developer of...

Added 17 days ago Industry news

Valeant Pharmaceuticals Inernational to be renamed Bausch Health Companies Inc.

Valeant Pharmaceuticals International, Inc. announced that the Company will change its name to Bausch Health Companies Inc., effective in July 2018. In an effort to turn around the company over the past two years, the Company has completed more than 

Added 17 days ago Industry news

Valeant Pharmaceuticals International to be renamed Bausch Health Companies Inc.

Valeant Pharmaceuticals Internatioonal will change its name to Bausch Health Companies Inc, effective in July 2018.